Two siblings with limb-girdle muscular dystrophy type 2E responsive to deflazacort

Neuromuscular Disorders

Volumn 20, Issue 2, 2010, Pages 122-124

  Wong Kisiel, Lily C ^a   Kuntz, Nancy L ^a  

^a Mayo Clinic   (United States)

Author keywords

deflazacort; Limb girdle muscular dystrophy; Sarcoglycanopathy

Indexed keywords

ACYLCARNITINE; ALANINE AMINOTRANSFERASE; AMMONIA; ASPARTATE AMINOTRANSFERASE; BETA SARCOGLYCAN; CREATINE KINASE; DEFLAZACORT; FRUCTOSE BISPHOSPHATE ALDOLASE; LACTATE DEHYDROGENASE; LACTIC ACID; PENTOXIFYLLINE; PYRUVIC ACID;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID BLOOD LEVEL; AMMONIA BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CELL COUNT; CASE REPORT; CHILD; CREATINE KINASE BLOOD LEVEL; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG RESPONSE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LACTATE BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIMB GIRDLE MUSCULAR DYSTROPHY; LORDOSIS; MALE; MISSENSE MUTATION; MUSCLE BIOPSY; MUSCLE STRENGTH; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SIBLING; SPIROMETRY; THYROID FUNCTION;

ADOLESCENT; BIOPSY; CHILD; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; PREGNENEDIONES; SARCOGLYCANS; SEVERITY OF ILLNESS INDEX; SIBLINGS; TREATMENT OUTCOME;

EID: 75149157950     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.11.005     Document Type: Article

References (10)

1. Duggan D.J., and Hoffman E.P. Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex. Neuromuscul Disord 6 6 (1996) 475-482
2. Moore S.A., Shilling C.J., Westra S., et al. Limb-girdle muscular dystrophy in the United States. J Neuropathol Exp Neurol 65 10 (2006) 995-1003
3. Lim L.E., Duclos F., Broux O., et al. Beta-sarcoglycan: characterization and role in limb-girdle muscular dystrophy linked to 4q12. Nat Genet 11 3 (1995) 257-265
4. Bonnemann C.G., Passos-Bueno M.R., McNally E.M., et al. Genomic screening for beta-sarcoglycan gene mutations: missense mutations may cause severe limb-girdle muscular dystrophy type 2E (LGMD 2E). Hum Mol Genet 5 12 (1996) 1953-1961
5. Ginjaar H.B., van der Kooi A.J., Ceelie H., et al. Sarcoglycanopathies in Dutch patients with autosomal recessive limb girdle muscular dystrophy. J Neurol 247 7 (2000) 524-529
6. Connolly A.M., Pestronk A., Mehta S., et al. Primary alpha-sarcoglycan deficiency responsive to immunosuppression over three years. Muscle Nerve 21 11 (1998) 1549-1553
7. Angelini C., Fanin M., Menegazzo E., et al. Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patient. Muscle Nerve 21 6 (1998) 769-775
8. Manzur A.Y., Kuntzer T., Pike M., et al. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 1 (2008) CD003725
9. Escolar D.M., Gorni K., Tesi-Rocha A.C., et al. Pentoxifylline treatment fails to rescue muscle strength and function deterioration in prednisone-treated Duchenne muscular dystrophy (DMD). Neuromuscul Disord 18 9-10 (2008) 824-825
10. Burdi R., Rolland J.F., Fraysse B., et al. Multiple pathological events in exercised dystrophic mdx mice are targeted by pentoxifylline: outcome of a large array of in vivo and ex vivo tests. J Appl Physiol 106 (2009) 1311-1324